mean age 15 58 9 (Gilead Sciences)
99
Structured Review
Gilead Sciences
mean age 15 58 9
![Some treatments of COVID-19]()
Mean Age 15 58 9, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 15423 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mean+age+15+58+9/VEKLURY/pmc09638654-3-86-92
Average 99 stars, based on 15423 article reviews
Mean Age 15 58 9, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 15423 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mean+age+15+58+9/VEKLURY/pmc09638654-3-86-92
Average 99 stars, based on 15423 article reviews
mean age 15 58 9 - by Bioz Stars,
2026-09
99/100 stars
Images
1) Product Images from "Evaluation of the diagnosis and treatment options for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"
Article Title: Evaluation of the diagnosis and treatment options for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Journal: Journal of Family Medicine and Primary Care
doi: 10.4103/jfmpc.jfmpc_1735_21
Figure Legend Snippet: Some treatments of COVID-19
Techniques Used: Filtration
Related Articles
Control:Article Title: Evaluation of the diagnosis and treatment options for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Article Snippet: Death in treatment group 5 and in control group 11 , 65 people (32 people in the treatment group, 32 people in the control group, mean age in the treatment group 65 years and in the control group 60 years) , Tocilizumab (TCZ), a human monoclonal antibody with basic therapy , [ ] . .. Mortality was 6.7% in the treatment group and 11.9% in the control group on day 15 and 11.4% in the treatment node compared to 15.2% in the control group by day 29. The most common unpleasant side effects in at least 5% of all patients: reduction glomerular filtration rate, decrease in hemoglobin level, decrease in lymphocyte count, respiratory failure, anemia, pyrexia, hyperglycemia, increase in blood creatinine level, and increase in blood glucose level , 1062 patients (541 in the treatment group, 521 in the control group), Filtration:Article Title: Evaluation of the diagnosis and treatment options for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Article Snippet: Death in treatment group 5 and in control group 11 , 65 people (32 people in the treatment group, 32 people in the control group, mean age in the treatment group 65 years and in the control group 60 years) , Tocilizumab (TCZ), a human monoclonal antibody with basic therapy , [ ] . .. Mortality was 6.7% in the treatment group and 11.9% in the control group on day 15 and 11.4% in the treatment node compared to 15.2% in the control group by day 29. The most common unpleasant side effects in at least 5% of all patients: reduction glomerular filtration rate, decrease in hemoglobin level, decrease in lymphocyte count, respiratory failure, anemia, pyrexia, hyperglycemia, increase in blood creatinine level, and increase in blood glucose level , 1062 patients (541 in the treatment group, 521 in the control group), |